Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryeli lillytirzepatidecompoundingfdalitigation

Eli Lilly sues weight clinic over allegedly illegal copies of its drugs

Lilly's filing accuses the clinic of flouting federal rules on unapproved versions of its incretin medicines.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 9 16:21 ETSource: Law360

The wire

  1. 01Law360 reports Eli Lilly has accused a weight-loss clinic of selling illegal copies of its drugs, saying the clinic 'mocks' the FDA.
  2. 02Lilly's litigation campaign against compounders and clinics continues to set the boundaries for cash-pay weight-loss operators and their supply partners.
  3. 03The allegations are untested in court and the clinic has not responded publicly; case details and any ruling are still to come.

From the source

Eli Lilly Says Weight Clinic 'Mocks' FDA With Illegal Drugs

Read at law360.com
PeptiPrescribed peptides from $99/moSee all →